Security Snapshot

Celularity Inc - Class A Common Stock, Par Value $0.0001 Per Share (CELU) Institutional Ownership

CUSIP: 151190204

13F Institutional Holders and Ownership History from Q1 2024 to Q3 2026

13F reference period

Q3 2026

Institutions Reporting

16

Shares (Excl. Options)

1.88MFull value: 1,876,099 · shares · 30 Sep 2026

Price

$1.35

The headline uses the Q3 2026 reference period after its reporting deadline. Available reports may still be incomplete or amended.

Save this security page for your next review

Watchlists follow companies and investors, across their share classes. Bookmark this page to revisit this specific CUSIP and its quarterly holders. If you create an account from here, we will bring you back after verification.

Latest holder snapshot 5 signals
Portfolio coverage rank
0%
Share change
+59,884
Value change
+$108,046
Number of holders
16
Issuer context Names, identifiers, and filing context for this profile. 3 identity fields
Shares outstanding
41,173,059
SEC-reported price per share
$1.42
Insider filing price
$1.42
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Filing notes and source

Key facts

  • CELU - Celularity Inc - Class A Common Stock, Par Value $0.0001 Per Share is tracked under CUSIP 151190204.
  • 16 institutions reported positions in Q3 2026.
  • 2 significant owners is listed from Schedule 13D/13G reporting.

Change

  • Holder count moved from 36 to 16 between Q2 2026 and Q3 2026.
  • SEC-reported value moved from
    $858.82KFull value: $858,817 · USD · 30 Jun 2026
    to
    $2.53MFull value: $2,532,780 · USD · 30 Sep 2026
    .

Research use

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Evidence

Source: SEC Form 13F

Latest holder context comes from 16 institutions filings for Q3 2026.

Open SEC evidence

Security key

151190204

13F reference period

Q3 2026

13F holders

16

13D/G owners

2

CIK / CUSIP context first

13D/G owners

Significant owners

Large-stake holder rows connected to Schedule 13D/G evidence.

Rows
2
Security
CELU
Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Dragasac Ltd 41% +13% $27,710,796 +$8,232,000 14,138,161 +42% Lim Kok Thay 24 Jul 2025
Philip & Daniele Barach Family Trust 29% +82% $18,865,495 +$10,152,292 11,940,187 +117% PHILIP & DANIELE BARACH FAMILY TRUST 23 Sep 2026
As of 30 Sep 2026, 16 institutional investors reported holding
1.88MFull value: 1,876,099 · shares · 30 Sep 2026
shares of Celularity Inc - Class A Common Stock, Par Value $0.0001 Per Share (CELU). This represents 4.6% of the company’s total
41.17MFull value: 41,173,059 · shares · Stored outstanding share count
outstanding shares.

Quarter history

Institutional holders across reporting periods

Holder count, reported shares/value, and median price by quarter.

Periods
11
Headline period
Q3 2026
Rows shown
1-11 of 11
Period 13F Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q3 1,876,099 $2,532,780 +$108,046 $1.35 16
2026 Q2 1,436,976 $858,817 -$45,832 $0.60 36
2026 Q1 2,169,041 $2,884,731 -$61,489 $1.33 37
2025 Q4 1,449,435 $1,608,923 -$277,872 $1.11 35
2025 Q3 2,299,817 $4,755,556 +$256,110 $2.07 38
2025 Q2 2,177,848 $4,267,509 +$13,254 $1.96 34
2025 Q1 1,981,476 $3,426,607 +$205,139 $1.73 29
2024 Q4 1,850,085 $3,848,006 +$219,913 $2.08 31
2024 Q3 964,511 $2,864,555 +$21,256 $2.97 26
2024 Q2 944,761 $2,956,741 +$298,532 $3.13 26
2024 Q1 836,863 $4,377,386 +$4,294,925 $5.23 30
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .